1354 related articles for article (PubMed ID: 17873108)
1. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
Nishioka J; Goodin S
J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
Burris HA
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
[TBL] [Abstract][Full Text] [Related]
3. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
Cunningham RS
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated thrombosis: focus on extended therapy with dalteparin.
Bick RL
J Support Oncol; 2006 Mar; 4(3):115-20. PubMed ID: 16553136
[TBL] [Abstract][Full Text] [Related]
5. Warfarin versus low-molecular-weight heparin therapy in cancer patients.
Zacharski LR; Prandoni P; Monreal M
Oncologist; 2005 Jan; 10(1):72-9. PubMed ID: 15632254
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of venous thrombosis in cancer patients: practical aspects].
Laza-Achille M; Desruennes E; Di Palma M
Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
[TBL] [Abstract][Full Text] [Related]
8. Cancer-related deep venous thrombosis: clinical importance, treatment challenges, and management strategies.
Deitcher SR
Semin Thromb Hemost; 2003 Jun; 29(3):247-58. PubMed ID: 12888929
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M;
N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587
[TBL] [Abstract][Full Text] [Related]
10. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
11. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
[TBL] [Abstract][Full Text] [Related]
12. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
13. Use of low-molecular-weight heparins in the treatment and secondary prevention of cancer-associated thrombosis.
Grande C; Caparro M
Semin Oncol Nurs; 2005 Nov; 21(4 Suppl 1):41-9. PubMed ID: 16360897
[TBL] [Abstract][Full Text] [Related]
14. Management of thromboembolism in patients with cancer.
Viale PH
Oncol Nurs Forum; 1999; 26(10):1625-32; quiz 1633-4. PubMed ID: 10573679
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated venous thrombosis in the surgical setting.
Behranwala KA; Williamson RC
Ann Surg; 2009 Mar; 249(3):366-75. PubMed ID: 19247020
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cancer-associated thrombosis: distinguishing among antithrombotic agents.
Pruemer J
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S26-39; quiz S41-2. PubMed ID: 16638458
[TBL] [Abstract][Full Text] [Related]
17. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.
Levine M
Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():9-11. PubMed ID: 14730472
[TBL] [Abstract][Full Text] [Related]
18. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States.
Caprini JA; Arcelus J; Sehgal LR; Cohen EB; Reyna JJ
Int Angiol; 2002 Mar; 21(1):78-85. PubMed ID: 11941278
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapy with low molecular weight heparin in cancer patients.
Petralia P; Kakkar AK
Eur J Med Res; 2004 Mar; 9(3):119-24. PubMed ID: 15096321
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism and cancer: prevention and therapy.
Lee AY
Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
